Expression of cyclic ADP-ribose - Synthetizing CD38 molecule on human platelet membrane

58Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

CD38 is a cell surface molecule widely used as a marker for immature and activated lymphocytes. It has been recently shown that CD38 displays three enzymatic activities: hydrolysis of NAD+ to ADP-ribose, synthesis of cyclic ADP-ribose from NAD+, and hydrolysis of cyclic ADP-ribose to ADP-ribose. Thus, CD38 plays a key role in the synthesis of cyclic ADP-ribose, a calcium-mobilizing compound. We investigate here the expression and cellular localization of CD38 in human platelets using a specific monoclonal antibody. Results showed that CD38 is expressed by human platelet membranes. Moreover, we show that platelet CD38 possesses NAD glycohydrolase, ADP-ribose cyclase, and cyclic ADP-ribose hydrolase activities. This finding indicates that the calcium-mobilizing agent cyclic ADP-ribose can be synthetized by human platelets and raises the question about the possible rote of CD38 expression and enzymatic activities in the signal transduction pathways leading to platelet activation. © 1996 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Ramaschi, G., Torti, M., Festetics, E. T., Sinigaglia, F., Malavasi, F., & Balduini, C. (1996). Expression of cyclic ADP-ribose - Synthetizing CD38 molecule on human platelet membrane. Blood, 87(6), 2308–2313. https://doi.org/10.1182/blood.v87.6.2308.bloodjournal8762308

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free